United States - English - NLM (National Library of Medicine)

cardinal health - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987) - xylocaine (lidocaine hcl) injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987) - xylocaine (lidocaine hcl) injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous - solution for injection - 1 % - active: lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment to ph 6.7-6.8 methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment to ph 6.7-6.8 water for injection active: lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection active: lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection active: lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: - local infiltration - minor or major nerve blocks - epidural block - arthroscopy - intravenous regional anaesthesia

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.0091 mg/ml equivalent to 5 µg/ml adrenaline;  ; lidocaine hydrochloride 10 mg/ml; adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]); lidocaine hydrochloride 10 mg/ml; adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]); lidocaine hydrochloride 10 mg/ml - solution for injection - active: adrenaline acid tartrate 0.0091 mg/ml equivalent to 5 µg/ml adrenaline   lidocaine hydrochloride 10 mg/ml excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]) lidocaine hydrochloride 10 mg/ml excipient: carbon dioxide hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]) lidocaine hydrochloride 10 mg/ml excipient: carbon dioxide hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: · local infiltration · minor or major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous - solution for injection - 2 % - active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment to ph 6.7-6.8 methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment to ph 6.7-.68 water for injection active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: - local infiltration - minor or major nerve blocks - epidural block - arthroscopy - intravenous regional anaesthesia

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.0091 mg/ml;  ; lidocaine hydrochloride 20 mg/ml; adrenaline acid tartrate 0.0091 mg/ml; lidocaine hydrochloride 20 mg/ml - solution for injection - active: adrenaline acid tartrate 0.0091 mg/ml   lidocaine hydrochloride 20 mg/ml excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml lidocaine hydrochloride 20 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: · local infiltration · minor or major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to 20 mg lignocaine hydrochloride anhydrous - oral solution - 2% w/v - active: lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: carmellose sodium cherry extract fache 5913g methyl hydroxybenzoate propyl hydroxybenzoate purified water saccharin sodium sodium hydroxide - xylocaine viscous solution is indicated for the relief of pain and discomfort associated with: · irritated or inflamed mucous membranes of the mouth, pharynx and upper gastrointestinal tract, e.g. post-tonsillectomy sore throat, dumping syndrome · introduction of instruments and catheters into the respiratory and gastrointestinal tract.

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - lignocaine hcl anhydrous - injection - 50 mg/5 ml - lignocaine hcl anhydrous 50 mg/5 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine, quantity: 100 mg/ml - spray, solution - excipient ingredients: ethanol; menthol; purified water; macrogol 400; saccharin; flavour - xylocaine 10% pump spray is used for surface anaesthesia of the mucous membranes prior to the following procedures:,otorhinolaryngology:,to prepare for puncture of the maxillary sinus; for analgesia of the pharynx to prevent gagging and stress reactions when inserting instruments.,dental practice:,before injections, treating minor abscesses, suture removal, deep scaling and to prevent gagging when taking intraoral impressions and x-rays.,general anaesthesia:,to prevent coughing with an endotracheal tube in situ during light surgical anaesthesia.,obstetrics:,during the final stages of delivery and before episiotomy and perineal suturing as supplementary pain control.

United States - English - NLM (National Library of Medicine)

cardinal health - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987) - xylocaine (lidocaine hcl) injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.